The text of this edition of Medical Technology Focus was kindly provided by Cook Women's Health.
International Women's Day is celebrated on 8 March, an occasion when women from all continents, often divided by ethnic, linguistic, cultural, economic and political differences, come together to celebrate. Today, women are more informed, and a focus on female specific healthcare from the medical community, is giving more women the opportunity to make informative choices regarding their health and treatment.
However, there is a long way to go. There has been a lot of discussion of late on the lack of female specific research and tailored product development in healthcare. The Journal of the Royal Society for Medicine published an article earlier this year looking at the importance of introducing legislation with gender specific research and clinical trials in mind. It is claimed that the exclusion of women from clinical trials and other associated medical research is potentially putting the health of millions of women at risk.
For women all over the world the research and development of innovative medical solutions has increased the quality of their lives. However, few have stopped to consider the significance of female specific research.
Healthcare is one area where we need to keep gender separate and develop a more in-depth understanding of physiological differences. Research indicates that differences in the intrauterine environment triggered by the foetus' sex may lay the groundwork for later health. These differences continue throughout life, establishing biological differences in health and disease. This means we have a responsibility to adopt dedicated approaches to healthcare for men and women.
There are now more treatment options available, partly because medical technology companies have dedicated research into the treatment of these conditions and are educating women on what options are available.
Below we look at three conditions, which are female specific and particularly common in women who have given birth. These include, post partum haemorrhage, pelvic organ prolapse and chronic pelvic pain.
POP occurs when the pelvic floor muscles become weak or damaged and can no longer support the pelvic organs. The womb (uterus) is the only organ that actually falls into the vagina. When the bladder and bowel slip out of place, they push up against the walls of the vagina. While prolapse is not considered a life threatening condition, it may cause a great deal of discomfort and distress.
Pelvic floor prolapse is classified into five categories:
The pelvic organs are kept in place by the muscles and connective tissues of the pelvis (pelvic diaphragm). The vagina of an adult woman is normally a round-topped, muscular tube that supports other pelvic organs. When the pelvic muscles and tissues are stretched or damaged, most commonly by pregnancy and childbirth, they lose their ability to support the organs. Prolapse can be partial or severe and mild genital prolapse may be asymptomatic. But generally, those common to all types of prolapse are feelings of dragging or a lump in the vagina. The following have also been noted in patients:
There are a number of options available to treat prolapse, including physiotherapy and surgery. The choice of treatment depends on a variety of factors, such as the type of prolapse, the severity of symptoms, a woman's age and other health issues, including whether or not a woman wants children in the future and personal preference.
POP can be a long-lasting condition, but it does not have to disrupt a woman's life. If symptoms are not relieved as a result of lifestyle changes, treatment will need to be considered, before considering surgery, options include:
Surgery is widely considered to be the best treatment for POP - about 85 percent of the patients who have surgery performed have no recurrence of the condition[4].
If surgery is the only option, there are some important differences between the materials that are currently used to repair prolapse.
These include:
Possible complications of pelvic reconstructive surgery include urinary tract infection, temporary or permanent incontinence, infection, bleeding and - rarely - damage to the urinary tract that requires additional corrective surgery. Some women may develop chronic irritation or pain during intercourse from a suture or scar tissue.
Many women are able to adjust their lifestyle habits with positive impact on the condition:
The risk of maternal death from childbirth represents one of the greatest risks in global health. Obstetric haemorrhage is the world's leading cause of maternal mortality, causing at least 25 percent of, or an estimated 127,000, maternal deaths annually. Post Partum Haemorrhage (PPH) is the most common type of obstetric haemorrhage and accounts for the majority of the 14 million cases of obstetric haemorrhage that occur each year[5]. Although various management measures are available to treat the haemorrhage, many of these options may still lead to hysterectomy or a separate surgical procedure.
The main risk for PPH due to uterine atony (failure of the uterus to contract properly after delivery) includes a large fetus, multiple fetuses or too much amniotic fluid (hydramnios). Retained fragments of the placenta, infection, and trophoblastic tumours can all produce delayed or secondary PPH, defined as haemorrhage after the first 24 hours but less than 6 weeks postpartum. Atony and retained placenta make up 80 percent of all cases, lacerations comprise the bulk of the other 20 percent[6].
PPH is very unpredictable; up to 90 percent of women who experience it have no identifiable risk factors.
Various management measures are utilised for control of bleeding, including, uterine packing, manual compression, embolisation (the insertion of a substance through a catheter into a blood vessel to stop haemorrhaging) and hysterectomy. The ideal choice for a patient's post partum haemorrhage will include easily administered and removed, control of capillary / venous bleeding and surface oozing, ability to gauge success of treatment in real time, and the avoidance of hysterectomy to preserve the patient's reproductive potential.
Hysterectomy can be an undesirable action to take and it is usually only undertaken when other traditional measure to stop haemorrhage fail. Uterine packing has been used successfully in many cases to conservatively manage post partum bleeding, however, removing such packing can sometimes require a separate surgical procedure to dilate and extract the materials. Therefore packing sometimes falls short of an ideal treatment option.
Active management of the third stage of labour can prevent 60 percent of uterine atony and is an evidence-based, feasible, low-cost intervention. Other preventative measures include reducing the incidence of prolonged labour (through monitoring and timely intervention, when needed) and minimising the trauma associated with instrumental delivery.
Physicians are also now able to navigate around conditions such as uterine atony with devices designed to address these specific conditions, eliminating additional risks. One innovating medical technology manufacturer has developed a post partum balloon that offers health care providers and their patients a potentially lifesaving device to aid in the treatment of postpartum bleeding. It has also proven to be an effective management device for postpartum uterine haemorrhage. The use of the balloon helps preserve the patient's fertility by potentially limiting the need for a hysterectomy to stop the bleeding.
Although various other management measures are available to treat the haemorrhage, many of these options may still lead to hysterectomy or a separate surgical procedure.
Chronic pelvic pain affects 15 percent of women ages 18-50 and has a drastic negative impact on the quality of a woman's life. Chronic pelvic pain refers to any pain in your pelvic region- that lasts six months or longer. It can be a symptom of another disease or it can be diagnosed as a condition in its own right. The ailment can be caused by a number of sources, including endometrioses, interstitial cystitis, pelvic injury and most often pelvic congestion syndrome. All of these causes are currently difficult to diagnose and treat because of the complicated design of the pelvis and determining what's causing the discomfort may be one of medicine's more puzzling and frustrating endeavours. 61 percent of women who experience chronic pelvic pain at some time during their lives never receive a specific diagnosis for their symptoms. Many times pelvic pain is just the normal functioning of the reproductive or other organs. Other times pelvic pain may indicate a serious problem that needs urgent treatment.
Chronic pelvic pain can have a combination of physical symptoms (pain, trouble sleeping, loss of appetite), psychological symptoms (depression) and changes in behaviour (change in relationships due to the physical and psychological problems).
Chronic pelvic pain exhibits many different characteristics. Among the signs and symptoms are:
Some of the more common causes of chronic pelvic pain include:
Characteristics of the pelvic veins make them vulnerable to chronic dilation, which can lead to vascular congestion. Pelvic veins are thin-walled, unsupported and are attached relatively weakly to supporting tissue. As a result they may bulge, stretch and dilate causing discomfort and pain in the form of pelvic congestion, which has similar symptoms to varicose veins. The condition is extremely severe and hinders an individual's ability to walk and exercise, sleep, conduct chores and in some cases activity at any level.
Figuring out what's at the root of chronic pelvic pain often involves a process of elimination, since the numerous disorders mentioned above could be responsible. Test or exams might include:
Possible treatments for chronic pelvic pain include:
Women often find that they need to try a combination of treatment approaches before finding one that works for them.
Advances in medical technology now enable a dynamic diagnosis of pelvic congestion in a matter of minutes and a fraction of the cost of other techniques. The device in question injects a water-soluble contrast medium into the uterine cavity and then into lining of the uterus to perform a pelvic venography. This provides physicians with a clear look at what is taking place within the pelvis. Physicians can then measure the amount of time it takes the fluid to travel through the pelvic veins. If the fluid is slow moving, that indicates a possible congestion. From this point physicians continue to track the amount of time it takes the fluid to travel - the longer this takes the higher the severity of congestion. This information allows physicians to fine tune diagnosis and determine the best treatment option for the patient based on the severity of their congestion.
One of the more frustrating aspects of chronic pain is that it can have significant impact on a woman's daily life. Often, self-care techniques can ease at least some of the discomfort.
Relaxation, deep breathing and targeted stretching exercises for the pelvic region can help minimise bouts of pain when they occur. It is also important to receive emotional support. Chronic pain can trigger some intense, negative emotions, such as pain, grief and anger, which can affect a woman's self-esteem and her relationships with others. Acknowledging and talking about their feelings is the first step toward emotional health. Stress management can also be an important step to good health. Getting too wound up and stressed over certain situations may exacerbate chronic pain. Effective stress management techniques not only help reduce the stress levels, but may also have the indirect effect of easing stress-triggered pain.
The advancement of gender specific research, and the development of devices tailored to conditions affecting women, have been major steps forward in improving quality of life for women world-wide. We hope that Women's Day 2008 will mark even more progress.
_______________________________________________
[1] Thakar R, Stanton S; Management of Genital Prolapse. BMJ; 324; 1258-1262.
[2] GyneaCare Women's Health Solutions, POP Fact Sheet, http://www.gynecare.com/content/backgrounders/www.womenhealth.info/www.womenhealth.info/Pelvic_Prolapse_Fact_Sheet.pdf
[3] Thakar R, Stanton S; Management of Genital Prolapse. BMJ; 324; 1258-1262.
[4] http://www.mwri.magee.edu/urogyne/prolapsetreatment.htm
[5] http://www.pphprevention.org/
[6] http://www.patient.co.uk/showdoc/40000261/
[7] http://www.mayoclinic.com/health/chronic-pelvic-pain/DS00571